| Company Name: |
3B Pharmachem (Wuhan) International Co.,Ltd.
|
| Tel: |
821-50328103-801 18930552037 |
| Email: |
3bsc@sina.com |
| Products Intro: |
Product Name:CCG 2046;3-Methyl-3-propyl-1,1,2,2-cyclopropanetetracarbonitrile
CAS:13017-69-1
Purity:99% HPLC Package:1Mg ; 5Mg;10Mg ;100Mg;250Mg ;500Mg ;1g;2.5g ;5g ;10g
|
| Company Name: |
BOC Sciences
|
| Tel: |
1-631-485-4226; 16314854226 |
| Email: |
info@bocsci.com |
| Products Intro: |
Product Name:CCG 2046
CAS:13017-69-1
Purity:>=99% by HPLC Remarks:Reach out to us for more information about custom solutions.
|
| Company Name: |
EMMX Biotechnology LLC
|
| Tel: |
888-539-0666 |
| Email: |
info@emmx.com |
| Products Intro: |
Product Name:CCG 2046
CAS:13017-69-1
Purity:98% HPLC Package:5mg;10mg;25mg;50mg;100mg;250mg;500mg;1g
|
CCG 2046 manufacturers
- CCG-2046
-
- $2500.00 / 100mg
-
2026-03-13
- CAS:13017-69-1
- Min. Order:
- Purity:
- Supply Ability: 10g
|
| | CCG 2046 Basic information |
| Product Name: | CCG 2046 | | Synonyms: | CCG 2046;3-Methyl-3-propyl-1,1,2,2-cyclopropanetetracarbonitrile;1,1,2,2-Cyclopropanetetracarbonitrile, 3-methyl-3-propyl- | | CAS: | 13017-69-1 | | MF: | C11H10N4 | | MW: | 198.228 | | EINECS: | | | Product Categories: | | | Mol File: | 13017-69-1.mol |  |
| | CCG 2046 Chemical Properties |
| Boiling point | 467.4±45.0 °C(Predicted) | | density | 1.17±0.1 g/cm3(Predicted) | | storage temp. | Desiccate at +4°C | | solubility | <19.82mg/ml in DMSO |
| | CCG 2046 Usage And Synthesis |
| Uses | CCG-2046 is a RGS4 inhibitor with an IC50 of 4.3 μM against RGS4-Gαo interaction signal[1]. | | Biological Activity | Inhibitor of regulator of G-protein signaling 4 (RGS4). Reduces the RGS4-G α o protein-protein interaction signal. | | IC 50 | RGS4: 4.3 μM (IC50) | | References | [1] Roman DL, et al. Identification of small-molecule inhibitors of RGS4 using a high-throughput flow cytometry protein interaction assay. Mol Pharmacol. 2007 Jan;71(1):169-75. DOI:10.1124/mol.106.028670 |
| | CCG 2046 Preparation Products And Raw materials |
|